08:30 - 09:00

Program Registration

09:00-09:45

Welcome
Jody Ruiu, Seton Hall Law School (New Jersey)

09:45-10:40

Aligning the “Why” and “How” of Compliance
Professor Timothy Glynn, Seton Hall Law School (New Jersey)

10:40-11:00

Break

11:00-12:30

Global Anti-Corruption Enforcement
Wilson Ang, Norton Rose Fulbright (Singapore)
Carol Ann Poindexter, Norton Rose Fulbright (Washington, D.C.)

12:30-13:30

Lunch

13:30-14:15

Interactive Exercise
Wilson Ang, Norton Rose Fulbright (Singapore)
Carol Ann Poindexter, Norton Rose Fulbright (Washington, D.C.)

14:15-15:25

Being the Focus of a Government Investigation
Yuet Ming Tham, Sidley Austin LLP (Hong Kong/Singapore)

15:25-15:45

Break

15:45-16:45

Data Protection Risks as Related to Anti-Corruption Compliance, Mergers & Acquisitions, and Internal Investigations
Ken Chia, Baker & McKenzie, Wong & Leow LLC (Singapore)

08:45

Sign-In

09:00-09:10

Key Concept Review & Corruption Quiz
Professor Timothy Glynn, Seton Hall Law School (New Jersey)

09:10-10:25

Anti-Corruption Settlements
Eric Carlson, Covington & Burling (Shanghai)

10:25-10:50

Break

10:50-11:55

China Healthcare Compliance Update
Eric Carlson, Covington & Burling (Shanghai)

11:55-13:00

Competition Law in Pharmaceutical & Medical Device Sectors with Korea Focus
Hwa-Soo Chung, Kim & Chang (Seoul)

13:00-14:00

Lunch

14:00-15:05

Pharma & Device Industry Codes: How Key Interactions are Regulated Under IFPMA, APACMed, and Korean Codes
Hwa-Soo Chung, Kim & Chang (Seoul)

15:05-15:25

Break

15:25-16:25

ASIA Transparency Trends & Challenges
Diva Duong, IQVIA (Paris)
Lucas Nicolet-Serra, Simmons & Simmons LLP (Singapore)

16:25-17:30

Compliance Officers Panel Discussion
Masood Ahmed, Sanofi Group (Singapore)
Maija Burtmanis, Senior Legal/Compliance Life Sciences Executive (Japan)
Ronald Goon, Johnson & Johnson (Singapore)
Paul Sumilas, Zimmer Biomet (Singapore)
Moderator: Professor Timothy Glynn, Seton Hall Law School (New Jersey)

17:30-19:00

Networking Reception for All Program Faculty & Attendees

08:45

Sign-In

09:00-10:00

Emerging Risk Area—Legal and Compliance Overview of Patient Programs
Maija Burtmanis, Senior Legal/Compliance Life Sciences Executive (Japan)

10:00-10:15

Break

10:15-12:00

Assessing Industry Relationships with Patients and Patient Organizations
Maija Burtmanis, Senior Legal/Compliance Life Sciences Executive (Japan)

12:00-13:00

Lunch

13:00-14:00

Assessing Third Party Risk
Masood Ahmed, Sanofi Group (Singapore)

14:00-15:10

Health Care in India: Regulatory Compliance – Prevention is Better Than a Cure
Dr. Milind Antani, Nishith Desai Associates (Mumbai)

15:10-15:20

Break

15:20-17:30

Interactive Session
Professor Timothy Glynn, Seton Hall Law School (New Jersey)

08:45

Sign-In

09:00-10:30

Data Analytics
Lem Chin Kok, KPMG (Singapore)

10:30-10:50

Break

10:50-11:50

Building an Effective Compliance Program & Team
Stephanie Chew, Edwards Lifesciences (Shanghai)

11:50-12:35

How To Be Recognized as a Trusted Compliance Professional
Young Sang Kwon, Johnson & Johnson (Singapore)

12:35-13:35

Lunch

13:35-14:05

Interactive Session – Part 1 Teamwork: evaluate proposed activities, assess business and legal risk, and develop recommendations
Teamwork

14:05-16:05

Interactive Session - Part 2 Team Presentations & Classroom Discussion
Ronald Goon, Johnson & Johnson (Singapore)

16:05-16:30

Closing Remarks and Awarding of Program Certificates